Skip to main content
Clinical Trials/NCT03437512
NCT03437512
Terminated
Not Applicable

Non-invasive Brain Stimulation in Adults Who Stutter

University of Michigan1 site in 1 country29 target enrollmentJune 25, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stuttering, Developmental
Sponsor
University of Michigan
Enrollment
29
Locations
1
Primary Endpoint
Change in Percentage of Stuttered Syllables Produced During Speech Sample
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

Research studies in stuttering have shown that activity patterns in certain brain areas differ in people who stutter compared to people who do not stutter when speaking. The purpose of this study is to investigate how mild, non-invasive brain stimulation applied consecutively for five days affects speech relevant brain areas, which may in turn affect speech fluency and speaking-related brain activity in people who stutter.

Registry
clinicaltrials.gov
Start Date
June 25, 2018
End Date
April 1, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Emily O'Dell Garnett

Research Investigator

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • history of persistent developmental stuttering
  • stuttering severity ranging from mild to very severe, specifically Stuttering Severity Instrument (SSI) total score of 20 (mild) or higher and stuttering rates of 3% or higher
  • scores within 1 standard deviation of the norm on the standardized tests for the study

Exclusion Criteria

  • received any treatment for stuttering within the past year
  • other neurological conditions such as Tourette's syndrome or post-traumatic stress disorder
  • taking any medications/drugs that affect brain function
  • history of past or current mental illness for example, schizophrenia that may affect brain development and function
  • history of serious medical or neurological illness such as epilepsy and Parkinson's disease
  • history of closed head injury (e.g., concussion)
  • history of reading disorders
  • hearing loss
  • taking any medication, prescription or non-prescription with any psychotropic effects at the time of the study
  • metal or electronic implants such as cochlear implants, and pacemakers

Outcomes

Primary Outcomes

Change in Percentage of Stuttered Syllables Produced During Speech Sample

Time Frame: Baseline, 1 week (post), 4 weeks (follow up)

Investigators will calculate the percentage of stuttered syllables (out of total syllables) in a speech sample. Decreased stuttered syllables represents better outcomes (greater reduction in stuttering).

Changes in Brain Activation as Assessed by fMRI Images

Time Frame: Baseline, 1 week (post), 4 weeks (follow up)

Investigators will use the fMRI images taken from before and after tDCS to determine if the treatment intervention contributed to any changes within brain regions associated with speech production. This will be measured by Blood-Oxygen-Level-Dependent (BOLD) signal change (arbitrary units). Images from scans are preprocessed. Changes in BOLD signal are modeled for contrasts within a group for \[post-pre\] and \[follow up-pre\] (e.g., active group reading condition post visit MINUS active group reading pre visit). Results are reported for reading condition.

Secondary Outcomes

  • Changes From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)(Baseline, 1 week (post), 4 weeks (follow up))

Study Sites (1)

Loading locations...

Similar Trials